CDMO & Sustainability: @CPhI 2022, Two pillars of Indena’s strategy to meet future challenges

From the 1st to the 3rd of November, at Messe Frankfurt (Booth 121B20), Indena welcomes clients, partners, experts and the media to share its vision, all its news and innovations in CDMO
(Custom Development Manufacturing Organization) and its CSR activities: two pillars of Indena’s strategy to face the challenges of the future. At CPhI 2022 Indena will also present some of its leading products, among which is CBD, the pharmaceutical-grade cannabidiol (CBD) produced by the company for the global market. “We join CPhI, one of the most important pharmaceutical events in the world, as protagonists of a market which continues to be robust despite the most recent issues due to the challenging economic and political situation. And we’re happy to have the opportunity, during CPhI 2022, to deep dive with our stakeholders into our CDMO experience, which has very solid and proven roots that are the point of departure to develop solutions for the clients who approach us. And this has been in Indena’s DNA for the last 100 years – says Francesca de Rensis, Marketing Director at Indena SpA -. At the same time we’ll present our actions in
favour of sustainability, which are not only an example of responsibility towards our planet and our future, but also an asset for competitive advantage and business continuity. Sustainability has become mainstream – adds de Rensis – Governments, NGOs, companies, people: everyone is directly involved and must play their part. This is a responsibility that Indena does not shirk, but is a concrete and wide-ranging commitment, starting from our smart management of energy”.

CUSTOM SERVICES: CREATING VALUE FOR THE PARTNERS
Custom Development and Manufacturing activities are truly part of Indena’s core expertise; it could be said that they are part of the company soul. In its CDMO services, Indena works for its partners with a spirit of service and also with the confidence that it is offering them a solution: after getting and understanding clients’ needs, Indena comes up with creative solutions that allow the project to progress from phase one to the commercial phase.

In each CDMO project Indena’s people endeavour to utilise their scientific curiosity and to create value for the partner, whether start-up Biotechs or big pharmaceutical industries; for the patient, who is the final beneficiary of the molecules the company develops with its partners; and in the end also for Indena itself, which continues to learn and develop new and more innovative solutions.

“Paraphrasing the CDMO acronym, we would say that Indena’s approach to custom services is made up of Curiosity for science, Development of knowledge, Mastering complexity and Obsession for quality – explains Pietro Allegrini, Indena’s R&D Director -. This is our formula for our clients’ success, and this has led Indena to become, for example, one of the most important producers of HPAPI worldwide”.